AdaptHealth Statistics
Total Valuation
AdaptHealth has a market cap or net worth of $1.32 billion. The enterprise value is $3.49 billion.
Important Dates
The next confirmed earnings date is Tuesday, November 5, 2024, before market open.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AdaptHealth has 130.53 million shares outstanding. The number of shares has decreased by -3.84% in one year.
| Shares Outstanding | 130.53M |
| Shares Change (YoY) | -3.84% |
| Shares Change (QoQ) | +2.34% |
| Owned by Insiders (%) | 11.29% |
| Owned by Institutions (%) | 67.65% |
| Float | 73.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.07 |
| PS Ratio | 0.42 |
| Forward PS | 0.38 |
| PB Ratio | 0.88 |
| P/FCF Ratio | 7.97 |
| PEG Ratio | 1.73 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.27, with an EV/FCF ratio of 20.97.
| EV / Earnings | n/a |
| EV / Sales | 1.07 |
| EV / EBITDA | 5.27 |
| EV / EBIT | 12.09 |
| EV / FCF | 20.97 |
Financial Position
The company has a current ratio of 1.15, with a Debt / Equity ratio of 1.49.
| Current Ratio | 1.15 |
| Quick Ratio | 0.86 |
| Debt / Equity | 1.49 |
| Debt / EBITDA | 3.09 |
| Debt / FCF | 13.41 |
| Interest Coverage | 2.20 |
Financial Efficiency
Return on equity (ROE) is -37.34% and return on invested capital (ROIC) is 4.38%.
| Return on Equity (ROE) | -37.34% |
| Return on Assets (ROA) | 3.71% |
| Return on Capital (ROIC) | 4.38% |
| Revenue Per Employee | $304,742 |
| Profits Per Employee | -$64,509 |
| Employee Count | 10,700 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 22.31 |
Taxes
| Income Tax | -38.83M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.84% in the last 52 weeks. The beta is 1.13, so AdaptHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | +19.84% |
| 50-Day Moving Average | 10.79 |
| 200-Day Moving Average | 10.06 |
| Relative Strength Index (RSI) | 41.42 |
| Average Volume (20 Days) | 590,437 |
Short Selling Information
The latest short interest is 10.14 million, so 7.77% of the outstanding shares have been sold short.
| Short Interest | 10.14M |
| Short Previous Month | 10.29M |
| Short % of Shares Out | 7.77% |
| Short % of Float | 13.75% |
| Short Ratio (days to cover) | 9.21 |
Income Statement
In the last 12 months, AdaptHealth had revenue of $3.26 billion and -$690.25 million in losses. Loss per share was -$5.26.
| Revenue | 3.26B |
| Gross Profit | 597.49M |
| Operating Income | 288.36M |
| Pretax Income | -730.11M |
| Net Income | -690.25M |
| EBITDA | 662.08M |
| EBIT | 288.36M |
| Loss Per Share | -$5.26 |
Full Income StatementBalance Sheet
The company has $74.72 million in cash and $2.23 billion in debt, giving a net cash position of -$2.15 billion or -$16.50 per share.
| Cash & Cash Equivalents | 74.72M |
| Total Debt | 2.23B |
| Net Cash | -2.15B |
| Net Cash Per Share | -$16.50 |
| Equity (Book Value) | 1.49B |
| Book Value Per Share | 11.48 |
| Working Capital | 90.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $501.12 million and capital expenditures -$334.90 million, giving a free cash flow of $166.22 million.
| Operating Cash Flow | 501.12M |
| Capital Expenditures | -334.90M |
| Free Cash Flow | 166.22M |
| FCF Per Share | $1.27 |
Full Cash Flow StatementMargins
Gross margin is 18.32%, with operating and profit margins of 8.84% and -21.20%.
| Gross Margin | 18.32% |
| Operating Margin | 8.84% |
| Pretax Margin | -22.26% |
| Profit Margin | -21.20% |
| EBITDA Margin | 20.30% |
| EBIT Margin | 8.84% |
| FCF Margin | 5.10% |
Dividends & Yields
AdaptHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.84% |
| Shareholder Yield | 3.84% |
| Earnings Yield | -52.10% |
| FCF Yield | 12.55% |
Dividend DetailsAnalyst Forecast
The average price target for AdaptHealth is $11.38, which is 12.12% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.38 |
| Price Target Difference | 12.12% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AdaptHealth has an Altman Z-Score of 1.02 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.02 |
| Piotroski F-Score | 6 |